These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 9233053)
1. Effects of sumatriptan on growth hormone releasing hormone-stimulated growth hormone secretion in acromegaly. Cuttica CM; Sessarego P; Ponzani P; Falivene MR; Valenti S; De Martini D; Giusti M Recenti Prog Med; 1997 Jun; 88(6):264-8. PubMed ID: 9233053 [TBL] [Abstract][Full Text] [Related]
2. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion. Mota A; Bento A; Peñalva A; Pombo M; Dieguez C J Clin Endocrinol Metab; 1995 Jun; 80(6):1973-7. PubMed ID: 7775648 [TBL] [Abstract][Full Text] [Related]
3. Sumatriptan does not stimulate PRL and GH secretion in acromegaly. Cuttica CM; Sessarego P; Valenti S; Falivene MR; Giusti M; Giordano G Minerva Endocrinol; 1995 Jun; 20(2):141-4. PubMed ID: 8531896 [TBL] [Abstract][Full Text] [Related]
4. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922 [TBL] [Abstract][Full Text] [Related]
5. Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects. Valcavi R; Zini M Clin Endocrinol (Oxf); 1994 Mar; 40(3):379-82. PubMed ID: 8187302 [TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly. Losa M; Schopohl J; König A; Müller OA; von Werder K J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly. Cuttica CM; Giusti M; Bocca L; Sessarego P; De Martini D; Valenti S; Spaziante R; Giordano G Neuroendocrinology; 1997 Dec; 66(6):426-31. PubMed ID: 9430448 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children. Guzzaloni G; Grugni G; Morabito F Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807 [TBL] [Abstract][Full Text] [Related]
9. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa. Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699 [TBL] [Abstract][Full Text] [Related]
10. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion. Gelato MC; Oldfield E; Loriaux DL; Merriam GR J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536 [TBL] [Abstract][Full Text] [Related]
11. Dopaminergic modulation of hexarelin-induced GH and PRL secretion in hyperprolactinemia. Foppiani L; Giusti M; Sessarego P; Guido R Recenti Prog Med; 1998 Mar; 89(3):118-22. PubMed ID: 9586422 [TBL] [Abstract][Full Text] [Related]
12. Growth hormone and prolactin response to growth hormone-releasing in anorexia nervosa. Lomeo A; Mazzocchi G; Sessarego P; Torre R; Delmonte P; Giusti M Recenti Prog Med; 1989 Nov; 80(11):569-73. PubMed ID: 2516349 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly. Orio F; Iovino M; Monteleone P; Agrusta M; Steardo L; Lombardi G Horm Metab Res; 1988 Nov; 20(11):701-4. PubMed ID: 2850985 [TBL] [Abstract][Full Text] [Related]
14. Cholinergic modulation of growth hormone, prolactin and thyroid stimulating hormone responses to thyrotropin-releasing hormone in normal aging. Giusti M; Giovale M; Sessarego P; Carraro A; Pompei A; Giordano G Recenti Prog Med; 1995 Sep; 86(9):341-4. PubMed ID: 7569294 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone-releasing hormone infusion in patients with active acromegaly. Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362 [TBL] [Abstract][Full Text] [Related]
16. The influence of age on human pancreatic growth hormone releasing hormone stimulated growth hormone secretion. Lang I; Kurz R; Geyer G; Tragl KH Horm Metab Res; 1988 Sep; 20(9):574-8. PubMed ID: 3143655 [TBL] [Abstract][Full Text] [Related]
17. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy. Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356 [TBL] [Abstract][Full Text] [Related]
18. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in acromegaly and type I diabetes mellitus. Pietschmann P; Schernthaner G; Luger A J Clin Endocrinol Metab; 1986 Aug; 63(2):389-93. PubMed ID: 3088023 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer. De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871 [TBL] [Abstract][Full Text] [Related]
20. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects. Massara F; Ghigo E; Demislis K; Tangolo D; Mazza E; Locatelli V; Müller EE; Molinatti GM; Camanni F Neuroendocrinology; 1986; 43(6):670-5. PubMed ID: 3093909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]